GHIGLIOTTI, GIORGIO
 Distribuzione geografica
Continente #
EU - Europa 14.671
Totale 14.671
Nazione #
IT - Italia 14.671
Totale 14.671
Città #
Genova 10.648
Rapallo 1.864
Genoa 1.324
Vado Ligure 789
Bordighera 46
Totale 14.671
Nome #
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 168
Cell-cell bond modulates vascular smooth muscle cell responsiveness to Angiotensin II 164
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 163
Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols. 154
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. 153
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 150
CD16+ monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers. 142
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 139
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 138
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 137
Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development 135
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 135
N-acetyl-cysteine reduces neointimal thickening and procoagulant activity after balloon-induced injury in abdominal aortae of NewZealand white rabbits 134
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 134
Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study. 133
Thrombolysis in refractory unstable angina. 132
Increased neutrophil lifespan in patients with congestive heart failure. 131
Carvedilol Prevents Doxorubicin-induced Free Radical release and Oxidative Damage in Cardiomyocytes. 129
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 127
Aurintricarboxylic Acid attenuates intimal thickening after balloon injury of the rabbit aorta. 127
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 125
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 125
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 124
Protective effects of Resveratrol in an experimental model of abdominal aortic aneurysm induction. 124
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 124
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 123
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 122
Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6. 121
Clinical stabilization of patients with unstable angina treated with thrombolytic therapy. 120
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 119
Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment. 118
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes 115
Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. 114
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 112
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 112
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. 109
Intravenous nifedipine prevents ergonovine-induced myocardial ischemia in patients with stable effort angina. 109
Pigmented nodular melanoma: The predictive value of dermoscopic features using multivariate analysis 109
Prolonged activation of prothrombin on the vascular wall after arterial injury. 109
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 108
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 108
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 105
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore Longitudinal Study of Aging. 105
Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway 105
Arterial hypertension in cancer: The elephant in the room 104
ERGONOVINE MALEATE TEST DETECTS ANGINAL PATIENTS WITH POORLY REPRODUCIBLE EXERCISE TESTS. 104
Role of advanced oxidation protein products and Thiol ratio in patients with acute coronary syndromes 102
Systemic levels of oxidative stress and title of autoantibodies in patients with ischemic heart disease at their first clinical manifestation. 102
Myostatin: A Playmaker in Chronic Kidney Disease and Vascular Damage 102
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes. 100
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 100
P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells 100
Plasmatic Levels of metalloproteinases 2 and 9 are increased in patients with congestive heart failure. 99
Role of cell-cell bond for the viability and the function of vascular smooth muscle cells. 98
Associazione tra lipoperossidazione ed insorgenza giovanile di aterosclerosi coronarica. 98
CD14CD16 monocyte subset levels in heart failure patients. 98
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 97
Early Age of onset of unstable angina is associated to major oxidative stress 97
Aspirin, but not heparin attenuates Xa/Va assembly after deep arterial injury of the rabbit aorta. 96
Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction 96
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 96
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline 95
Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities 94
Gallopamil and diltiazem: a double-blind, randomized, cross-over trial in effort ischaemia. 94
N-acetyl-cysteine Regulates the Response to Injury in NZW Rabbit Aorta. 94
Systemic vascular inflammation in abdominal aortic aneurysm patients: a contrast-enhanced PET/CT study 91
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 91
PROGENITOR CD34+ CELLS AND CIRCULATING ENDOTHELIAL CELLS IN PATIENTS WITH ACUTE OR CHRONIC HEART FAILURE 91
Plasma Levels of matrix metalloproteinase-9 and matrix metalloproteinase-2 are increased in plasma of patients with heart failure 90
Indoxyl sulfate: A candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease 90
Elevated plasma levels of lipid peroxidation are associated to an early onset of UA 89
Plasma Levels of Matrix metalloproteinase-2 are increased in plasma of patients with heart failure. 88
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 88
Two Takayasu arteritis patients successfully treated with rituximab. 88
LA DOXORUBICINA ALTERA L’ESPRESSIONE DELL’IGF-1R E DELL’IGFBP3 IN CELLULE MUSCOLARI CARDIACHE. UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ 88
UN PASTO IPERLIPIDICO INDUCE STRESS OSSIDATIVO DERIVATODALL’ATTIVITÀ DELLA MIELOPEROSSIDASI E DETERMINA L’AUMENTO DELL’ATTIVITÀ DELLE METALLOPROTEASI 87
Confronto fra meccanismi potenzialmente protettivi di carvedilolo e atenololo contro il danno e la morte di cellule muscolari cardiache indotti dalla doxorubicina in vitro. 86
HETEROGENEITY AND DIFFERENT RELATIONSHIP WITH BIOCHEMICAL AND INFLAMMATORY BIOMARKERS FOR THE CIRCULATING CD16+ MONOCYTES SUBSETS IN ABDOMINAL AORTIC ANEURYSMS (AAA) 86
Doxorubicin promotes metalloproteinases-2 trancriptional and zymographic activity in cardiac muscle cells via Nadph oxidase-derived reactive oxygen species. 86
Platelet-dependent and procoagulant mechanisms in arterial thrombosis. 85
Peaking time of CK-MB in patients treated with thrombolytic agents during myocardial infarction: is it really a clue to reperfusion? 85
Decreased Neointimal Proliferation by Inhibition of von Willebrand Factor Function 84
New therapeutic strategies in the management of congestive heart failure. 83
PROGNOSTIC VALUE OF BIPHASIC RESPONSE DURING DOBUTAMINE STRESS ECHO AFTER MYOCARDIAL-INFARCTION 83
Repeated balloon injury of the rabbit aorta increases thrombin binding and platelet deposition. 83
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 82
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 82
Pruritus characteristics in a large Italian cohort of psoriatic patients 82
Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy 81
Carbon nanotubes biocompatibility with Cardiac muscle cells 80
Autoanticorpi contro proteine ossidate in pazienti con recente sviluppo di angina instabile. 80
Thrombolytic therapy in refractory unstable angina: the role of Holter monitoring. 79
Familial Hypertophic Cardiomyopathy: many genes, how many diseases? 79
ADVANCED ABDOMINAL AORTIC ANEURYSMS DISPLAY ASPECIFIC INFLAMMATORY-PROATHEROSCLEROTIC PROFILEWITH RENAL DYSFUNCTION, RAISED D-DIMER, EXPANDEDCD14++CD16+-MONOCYTES HAVING HIGH CD143 77
Hypercholesterolemia and coronary disease: Intervention strategies. [L'ipercolesterolemia e malattia coronarica: strategie di intervento.] 77
Thrombus determinants of vascular cell activation. 77
ALTERAZIONI DELLE PROTEINE TELOMERICHE E SENESCENZA: UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ DA ANTRACICLINE 76
La doxorubicina induce nei cardiomiociti la metalloproteasi di tipo 2 attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 75
Resveratrol modulates systemic and perivascular inflammation in experimental abdominal aortic aneurysm 75
Early age of onset of unstable angina is associated with major oxidative stress 74
Totale 10.574
Categoria #
all - tutte 42.944
article - articoli 36.415
book - libri 600
conference - conferenze 5.412
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 517
Totale 85.888


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.221 0 0 0 0 330 370 578 193 338 778 444 190
2020/2021786 51 79 43 80 23 69 20 71 108 94 71 77
2021/20222.033 26 183 176 264 91 95 102 508 50 183 75 280
2022/20232.232 229 121 15 244 416 377 22 187 359 15 210 37
2023/2024939 38 128 14 99 87 187 53 75 80 13 49 116
2024/2025857 93 223 93 220 228 0 0 0 0 0 0 0
Totale 14.775